MIMEDX Comments on Prescience Point's Recent Filing
Shareholders Urged to Support MIMEDX Board MARIETTA, Ga., April 29, 2022 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the...
Stay updated with breaking news from Timothyr Wright. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shareholders Urged to Support MIMEDX Board MARIETTA, Ga., April 29, 2022 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the...
Wall Street analysts expect that MiMedx Group, Inc. (NASDAQ:MDXG – Get Rating) will report $54.10 million in sales for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for MiMedx Group’s earnings, with estimates ranging from $54.00 million to $54.20 million. MiMedx Group posted sales of $59.97 million in the same quarter last […]
MiMedx Group (NASDAQ:MDXG – Get Rating) issued its quarterly earnings results on Monday. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.04, MarketWatch Earnings reports. During the same period last year, the firm earned ($0.17) EPS. MiMedx Group updated its FY 2022 guidance to EPS. […]
Company to Share Probability Values from its Knee Osteoarthritis (KOA) Study; Analyses Conducted Support Confidence in Initiation of Confirmatory Phase 3...
Urges Shareholders to Vote the WHITE Proxy Card “FOR ALL” Four of MIMEDX’s Director Nominees – Dr. Kathleen Behrens, Mr. Todd Newton, Mr. Timothy Wright, and Dr. Phyllis Gardner Entirely Reconstituted Board and New Management Team Positioned Company for Long-Term Sustainable Growth; Stock Price Appreciation of 237% Since Timothy Wright Selected as CEO Virtual Annual Meeting to Be Held on May 27, 2021 MARIETTA, Ga., May 03, 2021 (GLOBE NEWSWIRE) -- MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for ...